Viewing Study NCT01875003


Ignite Creation Date: 2025-12-24 @ 7:09 PM
Ignite Modification Date: 2026-02-20 @ 5:56 PM
Study NCT ID: NCT01875003
Status: COMPLETED
Last Update Posted: 2017-05-16
First Post: 2013-06-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module